Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBenchmark Holdings Regulatory News (BMK)

  • There is currently no data for BMK

Share Premium Reduction

21 Mar 2023 17:33

RNS Number : 7702T
Benchmark Holdings PLC
21 March 2023
 

21 March 2023

 

Benchmark Holdings plc

("Benchmark" or the "Company")

Share Premium Reduction

21 March 2023

The Company announces that the cancellation of its share premium account (the "Capital Reduction"), which was approved by shareholders on 16 February 2023, is now effective. This follows the confirmation of the Capital Reduction by the High Court of England and Wales on 14 March 2023 and the registration of the Court order with the Registrar of Companies on 20 March 2023.

The Capital Reduction creates additional distributable reserves to the value of £394,235,072. The Company confirms that, following the Capital Reduction, the issued share capital of the Company remains at 739,277,469 ordinary shares of £0.001 each. The total number of voting rights in the Company also remains at 739,277,469.

Enquiries

 

For further information, please contact:

Benchmark Holdings plc

Tel: 0114 240 9939

Ivonne Cantu, Investor Relations

Numis (Broker and NOMAD)

Tel: 020 7260 1000

James Black, Freddie Barnfield, Duncan Monteith

MHP

Tel: 020 3128 8793 

Katie Hunt, Reg Hoare, Veronica Farah

benchmark@mhpgroup.com

 

About Benchmark

Benchmark is a market leading aquaculture biotechnology company. Benchmark's mission is to drive sustainability in aquaculture by delivering mission-critical products and solutions in genetics, advanced nutrition and health which improve yield, growth and animal health and welfare. Through a global footprint in 26 countries and a broad portfolio of products and solutions, Benchmark addresses the major aquaculture species - salmon, shrimp, sea bass and bream, and tilapia, in all the aquaculture regions around the world.

Find out more at www.benchmarkplc.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUAOBROUUOUAR
Date   Source Headline
12th Aug 20197:00 amRNSQ3 Trading Update
31st Jul 20191:15 pmRNSReplacement: Total Voting Rights
31st Jul 20197:00 amRNSTotal Voting Rights
11th Jul 20197:00 amRNSGenetics Breakthrough in Tilapia
9th Jul 20197:00 amRNSDirectorate Change
2nd Jul 20193:49 pmRNSHolding(s) in Company
2nd Jul 20197:00 amRNSHolding(s) in Company
28th Jun 20194:41 pmRNSSecond Price Monitoring Extn
28th Jun 20194:35 pmRNSPrice Monitoring Extension
28th Jun 20192:05 pmRNSSecond Price Monitoring Extn
28th Jun 20192:00 pmRNSPrice Monitoring Extension
28th Jun 20197:00 amRNSTotal Voting Rights
25th Jun 20197:00 amRNSInterim Results
13th Jun 20198:00 amRNSPlacement of a new senior secured bond issue
10th Jun 20197:00 amRNSUpdate on Joint Venture with AquaChile
3rd Jun 20197:00 amRNSTrading Update and Investor Meetings
31st May 20197:00 amRNSTotal Voting Rights
29th May 20197:00 amRNSUpdate on Joint Venture with AquaChile
30th Apr 20197:00 amRNSTotal Voting Rights
29th Mar 20192:25 pmRNSReplacement: Total Voting Rights
29th Mar 20197:00 amRNSTotal Voting Rights
21st Mar 20197:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
14th Mar 201912:21 pmRNSResult of AGM
28th Feb 20197:00 amRNSTotal Voting Rights
20th Feb 20197:00 amRNSAppointment of Non-Executive Director
29th Jan 20193:07 pmRNSPosting of Annual Report & Notice of AGM
28th Jan 20198:00 amRNSDIRECTOR SHARE OPTIONS
24th Jan 20197:00 amRNSFull Year Results
14th Jan 20197:00 amRNSNotice of Results
31st Dec 20188:00 amRNSTotal Voting Rights
12th Dec 20183:08 pmRNSDirector/PDMR Shareholding
12th Dec 201811:01 amRNSHolding(s) in Company
10th Dec 20185:05 pmRNSHolding(s) in Company
7th Dec 20183:35 pmRNSHolding(s) in Company
30th Nov 20187:00 amRNSTotal Voting Rights
30th Nov 20187:00 amRNSTotal Voting Rights
27th Nov 20187:00 amRNSSuccessful defence of patent infringement in Asia
7th Nov 20187:00 amRNSTrading Statement
31st Oct 20187:00 amRNSTotal Voting Rights
23rd Oct 20184:55 pmRNSHolding(s) in Company
22nd Oct 20185:52 pmRNSHolding(s) in Company
10th Oct 20182:53 pmRNSDIRECTOR DEALINGS
3rd Oct 20187:00 amRNSAcquisition and Issue of Equity
2nd Oct 20187:00 amRNSAppointment of Chief Scientific Officer
28th Sep 20187:00 amRNSTotal Voting Rights
21st Sep 20187:00 amRNSBlock listing Interim Review
12th Sep 20187:00 amRNSBlock Admission Application
10th Sep 20187:00 amRNSCommencement of salmon egg production in Salten
30th Aug 20187:00 amRNSTotal Voting Rights
30th Jul 20187:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.